Chapter 4
Adults and Mental Health

Chapter Overview

Anxiety Disorders

Mood Disorders


Service Delivery

Other Services And Supports




Aagaard, J., Vestergaard, P., & Maarbjerg, K. (1988). Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry, 21, 166–170.

Abbruzzese, M., Ferri, S., & Scarone, S. (1997). The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: A double dissociation experimental finding. Neuropsychologia, 35, 907–912.

Abram, K., & Teplin, L. (1991). Co-occurring disorders among mentally ill jail detainees: Implications for public policy. American Psychologist, 46, 1036–1046.

Adams, W., Kendell, R. E., Hare, E. H., & Munk-Jorgensen, P. (1993). Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. British Journal of Psychiatry, 163, 522–534.

Adolphs, R., Tranel, D., & Damasio, A. R. (1998). The human amygdala in social judgement. Nature, 393, 470–474.

Agency for Healthcare Research and Quality (AHRQ). (1999). Treatment of depression—newer pharmacotherapies (Evidence Report/Technology Assessment, Number 7, Pub. No. 99–E014). Rockville, MD: Author.

Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., Pancheri, P., Ravizza, L., Trabucchi, M., Bolino, F., Scarpato, A., Berardi, D., Provenzano, G., Brugnoli, R., & Rozzini, R. (1993). Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. International Clinical Psychopharmacology, 8, 197–202.

Aiken, L., Somers, S., & Shore, M. (1986). Private foundations in health affairs: A case study of a national initiative for the chronically mentally ill. American Psychologist, 41, 1290–1295.

Akbarian, S., Bunney, W. E. J., Potkin, S. G., Wigal, S. B., Hagman, J. O., Sandman, C. A., & Jones, E. G. (1993). Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Archives of General Psychiatry, 50, 169–177.

Akiskal, H. S. (1985). Interaction of biologic and psychologic factors in the origin of depressive disorders. Acta Psychiatrica Scandinavica., 319(Suppl.), 131–139.

Alexander, M. J. (1996). Women with co-occurring addictive and mental disorders: An emerging profile of vulnerability. American Journal of Orthopsychiatry, 66, 61–70.

Alexander, P. C., Neimeyer, R. A., & Follette, V. M. (1991). Group therapy for women sexually abused as children: Controlled study and investigation of individual differences. Journal of Interpersonal Violence, 6, 218–231.

Alexander, P. C., Neimeyer, R. A., Follette, V. M., Moore, M. K., & Harter, S. (1989). A comparison of group treatments of women sexually abused as children. Journal of Consulting and Clinical Psychology, 57, 479–483.

Allness, D. & Knoedler, W. (1999). Recommended PACT standards for new teams [On-line]. Available: about/pactstd.html

Alloy, L. B., & Abramson, L. Y. (1988). Depressive realism: Four theoretical perspectives. In Alloy L. B. (Ed.), Cognitive processes in depression (pp. 223–265). New York: Guilford Press.

Alloy, L. B., Peterson, C., Abramson, L. Y., & Seligman, M. E. (1984). Attributional style and the generality of learned helplessness. Journal of Personality and Social Psychology, 46, 681–687.

American Psychiatric Association. (1993). Practice guideline for major depressive disorder in adults. American Journal of Psychiatry, 150(Suppl. 4), 1–26.

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Psychiatric Association. (1998). Practice guidelines for the treatment of patients with panic disorder. American Journal of Psychiatry, 155(Suppl. 12), 1–34.

Andersson, C., Chakos, M., Mailman, R., & Lieberman, J. (1998). Emerging roles for novel antipsychotic medications in the treatment of schizophrenia. Psychiatric Clinics of North America, 21, 151–179.

Andrade, C., Gangadhar, B. N., Subbakrishna, D. K., Channabasavanna, S. M., & Pradhan, N. (1998). A double-blind comparision of sinusoidal wave and brief-pulse electroconvulsive therapy in endogenous depression. Convulsive Therapy, 4, 297–305.

Andreasen, N. C. (1995). Symptoms, signs, and diagnosis of schizophrenia. Lancet, 346, 477B-481.

Andreasen, N. C. (1997a). The evolving concept of schizophrenia: From Kraepelin to the present and future. Schizophrenia Research, 28, 105–109.

Andreasen, N. C. (1997b). Linking mind and brain in the study of mental illnesses: A project for a scientific psychopathology. Science, 275, 1586–1593.

Andreasen, N. C., O'Leary, D. S., Cizadlo, T., Arndt, S., Rezai, K., Ponto, L. L., Watkins, G. L., & Hichwa, R. D. (1996). Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proceedings of the National Academy of Sciences of the United States of America, 93, 9985–9990.

Andreasen, N. C., O'Leary, D. S., Flaum, M., Nopoulos, P., Watkins, G. L., Boles Ponto, L. L., & Hichwa, R. D. (1997). Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients. Lancet, 349, 1730–1734.

Andreasen, N. C., Paradiso, S., & O'Leary, D. S. (1998). "Cognitive dysmetria" as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical-cerebellar circuitry? Schizophrenia Bulletin, 24, 203–218.

Andrews, G. (1995). Workforce deployment: Reconciling demands and resources. Australian and New Zealand Journal of Psychiatry, 29, 394–402.

Angst, J., Angst, F., & Stassen, H. H. (1999). Suicide risk in patients with major depressive disorder. Journal of Clinical Psychiatry, 60(Suppl. 2), 57–62.

Appleby, L., Desai, P. N., Luchins, D. J., Gibbons, R. D., & Hedeker, D. R. (1993). Length of stay and recidivism in schizophrenia: A study of public psychiatric hospital patients. American Journal of Psychiatry, 150, 72–76.

Arborelius, L., Owens, M. J., Plotsky, P. M., & Nemeroff, C. B. (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. Journal of Endocrinology, 160, 1–12.

Armitage, R., Rush, A. J., Trivedi, M., Cain, J., & Roffwarg, H. P. (1994). The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology, 10, 123–127.

Arnold, S. E., Hyman, B. T., Van Hoesen, G. W., & Damasio, A. R. (1991). Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry, 48, 625–632.

Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., Richelson, E., & Sulser, F. (1995). Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry, 56, 395–401.

Attkisson, C., Cook, J., Karno, M., Lehman, A., McGlashan, T. H., Meltzer, H. Y., O'Connor, M., Richardson, D., Rosenblatt, A., Wells, K., & Williams, J., & Hohmann, A. A. (1992). Clinical services research. Schizophrenia Bulletin, 18, 561–626.

Awad, G. A., Voruganti, L. N., & Heslegrave, R. J. (1997). Measuring quality of life in patients with schizophrenia. Pharmacoeconomics, 11, 32–47.

Baldessarini, R. J., Cohen, B. M., & Teicher, M. H. (1990). Pharmacological treatment. In S. T. Levy & P. T Ninan (Eds.), Schizophrenia: Treatment of acute psychotic episodes (pp. 61–118). Washington, DC: American Psychiatric Press.

Baldwin, D. S., & Birtwistle, J. (1998). The side effect burden associated with drug treatment of panic disorder. Journal of Clinical Psychiatry, 59(Suppl. 8), 39–44.

Ball, F. L., & Havassy, B. E. (1984). A survey of the problems and needs of homeless consumers of acute psychiatric services. Hospital and Community Psychiatry, 35, 917–921.

Ballenger, J. C., Davidson, J. R., Lecrubier, Y., Nutt, D. J., Bobes, J., Beidel, D. C., Ono, Y., & Westenberg, H. G. (1998). Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry, 59(Suppl. 17), 54–60.

Ballus, C. (1997). Effects of antipsychotics on the clinical and psychosocial behavior of patients with schizophrenia. Schizophrenia Research, 28, 247–255.

Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191–215.

Barbee, J. G. (1998). Mixed symptoms and syndromes of anxiety and depression: Diagnostic, prognostic, and etiologic issues. Annals of Clinical Psychiatry, 10, 15–29.

Barlow, D. H. (1988). Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford Press.

Barlow, D. H., Chorpita, B. F., & Turovsky, J. (1996). Fear, panic, anxiety, and disorders of emotion. In D. A. Hope (Ed.), Perspectives on anxiety, panic, and fear (The 43rd Annual Nebraska Symposium on Motivation, pp. 251–328). Lincoln, NE: Nebraska University Press.

Barlow, D. H., & Lehman, C. L. (1996). Advances in the psychosocial treatment of anxiety disorders. Implications for national health care. Archives of General Psychiatry, 53, 727–735.

Barnes, T. R., & McPhillips, M. A. (1998). Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. International Clinical Psychopharmacology, 13(Suppl. 3), S49–S57.

Baron, M. (1997). Genetic linkage and bipolar affective disorder: Progress and pitfalls. Molecular Psychiatry, 2, 200–210.

Barta, P. E., Pearlson, G. D., Powers, R. E., Richards, S. S., & Tune, L. E. (1990). Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. American Journal of Psychiatry, 147, 1457–1462.

Bartels, S. J., Drake, R. E., & Wallach, M. A. (1995). Long-term course of substance use disorders among patients with severe mental illness. Psychiatric Services, 46, 248–251.

Basso, M. R., Nasrallah, H. A., Olson, S. C., & Bornstein, R. A. (1997). Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 10, 107–112.

Basso, M. R., Nasrallah, H. A., Olson, S. C., & Bornstein, R. A. (1998). Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia Research, 31, 99–111.

Bauer, M. S., Calabrese, J., Dunner, D. L., Post, R., Whybrow, P. C., Gyulai, L., Tay, L. K., Younkin, S. R., Bynum, D., Lavori, P., & Price, R. A. (1994). Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. American Journal of Psychiatry, 151, 506–515.

Baxter, L. R., Jr., Mazziotta, J. C., Phelps, M. E., Selin, C. E., Guze, B. H., & Fairbanks, L. (1987). Cerebral glucose metabolic rates in normal human females versus normal males. Psychiatry Research, 21, 237–245.

Beardslee, W. R., & Vaillant, G. (1997). Adult development. In A. Tasman, J. Kay, & J. A. Lieberman (Eds.), Psychiatry (Vol. 1, pp. 145–155). Philadelphia: W. B. Saunders.

Beasley, C. M., Jr., Dornseif, B. E., Bosomworth, J. C., Sayler, M. E., Rampey, A. H., Jr., Heiligenstein, J. H., Thompson, V. L., Murphy, D. J., & Masica, D. N. (1991). Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression. British Medical Journal, 303, 685–692.

Beasley, C. M., Jr., Sayler, M. E., Cunningham, G. E., Weiss, A. M., & Masica, D. N. (1990). Fluoxetine in tricyclic refractory major depressive disorder. Journal of Affective Disorders, 20, 193–200.

Bebbington, P., & Kuipers, L. (1994). The predictive utility of expressed emotion in schizophrenia: An aggregate analysis. Psychological Medicine, 24, 707–718.

Beck, A. T. (1976). Cognitive therapy and the emotional disorders. New York: International Universities Press.

Beck, A. T., Rush A. J., & Shaw B. F. (1979). Cognitive therapy of depression. New York: Guilford Press.

Bell, C. C. & Mehta, H. (1981). The misdiagnosis of black patients with manic depressive illness. Journal of the National Medical Association 73, 101–107.

Bell, M. D., & Lysaker, P. H. (1997). Clinical benefits of paid work activity in schizophrenia: 1-year followup. Schizophrenia Bulletin, 23, 317–328.

Bell, M. D., Lysaker, P. H., & Milstein, R. M. (1996). Clinical benefits of paid work activity in schizophrenia. Schizophrenia Bulletin, 22, 51–67.

Bell, M. D., & Ryan, E. R. (1984). Integrating psychosocial rehabilitation into the hospital psychiatric service. Hospital and Community Psychiatry, 35, 1017–1022.

Bellack, A. S., & Gearon, J. S. (1998). Substance abuse treatment for people with schizophrenia. Addictive Behaviors, 23, 749–766.

Bellack, A. S., Morrison, R. L., & Mueser, K. T. (1989). Social problem solving in schizophrenia. Schizophrenia Bulletin, 15, 101–116.

Bellack, A. S., & Mueser, K. T. (1993). Psychosocial treatment for schizophrenia. Schizophrenia Bulletin, 19, 317–336.

Berren, M., Hill, K., Merikle, E., Gonzalez, N., & Santiago, J. (1994). Serious mental illness and mortality rates. Hospital and Community Psychiatry, 45, 604–605.

Bertelsen, A., Harvald, B., & Hauge, M. (1977). A Danish twin study of manic-depressive disorders. British Journal of Psychiatry, 130, 330–351.

Besio, S. W., & Mahler, J. (1993). Benefits and challenges of using consumer staff in supported housing services. Hospital and Community Psychiatry, 44, 490–491.

Bezold, H. S., MacDowell M., & Kunkel R. (1996). Predicting psychiatric length of stay. Administration and Policy in Mental Health, 23, 407–423.

Bierut, L. J., Heath, A. C., Bucholz, K. K., Dinwiddie, S. H., Madden, P. A., Statham, D. J., Dunne, M. P., & Martin, N. G. (1999). Major depressive disorder in a community-based twin sample: Are there different genetic and environmental contributions for men and women? Archives of General Psychiatry, 56, 557–563.

Black, D. W., Winokur, G., & Nasrallah, A. (1987). The treatment of depression: Electroconvulsive therapy v antidepressants: A naturalistic evaluation of 1,495 patients. Comprehensive Psychiatry, 28, 169–182.

Blackburn, I. M., Eunson, K. M., & Bishop, S. (1986). A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders, 10, 67–75.

Blanchard, J. J., Mueser, K. T., & Bellack, A. S. (1998). Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophrenia Bulletin, 24, 413–424.

Blehar, M. C., DePaulo, J. R. Jr, Gershon, E. S., Reich, T., Simpson, S. G., & Nurnberger, J. I. Jr. (1998). Women with bipolar disorder: Findings from the NIMH Genetics Initiative sample. Psychopharmacology Bulletin, 34, 239–243.

Bloom, F. E. (1993). Advancing a neurodevelopmental origin for schizophrenia. Archives of General Psychiatry, 50, 224–227.

Blumenthal, S. J. (1988). Suicide: A guide to risk factors, assessment, and treatment of suicidal patients. Medical Clinics of North America, 72, 937–971.

Blumenthal, S. J. (1994a). Gender differences in mental disorders. Journal of Clinical Psychiatry, 3, 453–458.

Blumenthal, S. J. (1994b). Women and depression. Journal of Women's Health, 3, 467–453.

Bogerts, B., Lieberman, J. A., Ashtari, M., Bilder, R. M., Degreet, G., & Lerner, G. (1993). Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33, 236–246.

Bolden-Watson, C., & Richelson, E. (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sciences, 52, 1023–1029.

Bond, G. R., & Dincin, J. (1986). Accelerating entry into transitional employment in a psychosocial rehabilitation agency. Rehabilitation Psychology, 31, 143–154.

Bond, G. R., Drake, R. E., Mueser, K. T., & Becker, D. R. (1997). An update on supported employment for people with severe mental illness. Psychiatric Services, 48, 335–346.

Bond, G. R., McGrew, J. H., & Fekete, D. M. (1995). Assertive outreach of frequent users of psychiatric hospitals: A meta-analysis. Journal of Mental Health Administration, 22, 4–16.

Borkman, T. J. (1997). A selected look at self-help groups in the U.S. Health and Social Care in the Community, 5, 357–364.

Borkman, T. J. (1991). Self-help groups. Introduction to the special issue. American Journal of Community Psychology, 19, 643–650.

Borland, A., McRae, J., & Lycan, C. (1989). Outcome of five years of continuous intensive case management. Hospital and Community Psychiatry, 40, 369–376.

Bowden, C. L., Brugger, A. M., Swann, A. C., Calabrese, J. R., Janicak, P. G., Petty, F., Dilsaver, S. C., Davis, J. M., Rush, A. J., Small, J. G., Garza-Treviño, E. S., Risch, S. C., Goodnick, P. J., & Morris, D. D. (1994). Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association, 271, 918–924.

Bracha, H. S. (1991). Etiology of structural asymmetry in schizophrenia: An alternative hypothesis. Schizophrenia Bulletin, 17, 551–553.

Braun, C. M., Lapierre, D., Hodgins, S., Toupin, J., Leveille, S., & Constantineau, C. (1995). Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance and violence? Archives of Clinical Neuropsychology, 10, 489–509.

Brawman-Mintzer, O., & Lydiard, R. B. (1996). Generalized anxiety disorder: Issues in epidemiology. Journal of Clinical Psychiatry, 57(Suppl. 7), 3–8.

Brazo, P., & Dollfus, S. (1997). Syndromic and diagnostic heterogeneity of schizophrenia. Encephale, 23, 20–24.

Breggin, P. R., & Breggin, G. R. (1994). Talking back to Prozac. New York: St. Martin's Press.

Breiter, H. C., Etcoff, N. L., Whalen, P. J., Kennedy, W. A., Rauch, S. L., Buckner, R. L., Strauss, M. M., Hyman, S. E., & Rosen, B. R. (1996). Response and habituation of the human amygdala during visual processing of facial expression. Neuron, 17, 875–887.

Brekke, J. S., & Barrio, C. (1997). Cross-ethnic symptom differences in schizophrenia: The influence of culture and minority status. Schizophrenia Bulletin, 23, 305–316.

Brekke, J. S., Raine, A., & Thomson, C. (1995). Cognitive and psychophysiological correlates of positive, negative, and disorganized symptoms in the schizophrenia spectrum. Psychiatry Research, 57, 241–250.

Breslau, N., Davis, G. C., Andreski, P., & Peterson, E. (1991). Traumatic events and posttraumatic stress disorder in an urban population of young adults. Archives of General Psychiatry, 48, 216–222.

Breslau, N., Kessler, R. C., Chilcoat, H. D., Schultz, L. R., Davis, G. C., & Andreski, P. (1998). Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma. Archives of General Psychiatry, 55, 626–632.

Briere J. (1992). Child abuse trauma: Theory and treatment of the lasting effects. Newbury Park, CA: Sage.

Brixey, S. N., Gallagher, B. J., III, McFalls, J. A., Jr., & Parmelee, L. F. (1993). Gestational and neonatal factors in the etiology of schizophrenia. Journal of Clinical Psychology, 49, 447–456.

Broadhead, W. E., Blazer, D. G., George, L. K., & Tse, C. K. (1990). Depression, disability days, and days lost from work in a prospective epidemiologic survey. Journal of the American Medical Association, 264, 2524–2528.

Brown, G. W., & Harris, T. O. (1989). Life events and illness. New York: Guilford Press.

Brown, G. W., Harris, T. O., & Hepworth, C. (1994). Life events and endogenous depression. A puzzle reexamined. Archives of General Psychiatry, 51, 525–534.

Brown, G. W., & Moran, P. M. (1997). Single mothers, poverty and depression. Psychological Medicine, 27, 21–33.

Brown, S. (1997). Excess mortality of schizophrenia—A meta-analysis. British Journal of Psychiatry, 171, 502–508.

Browne, A., & Finkelhor, D. (1986). Impact of child sexual abuse: A review of the research. Psychological Bulletin, 99, 66–77.

Buchanan, R. W. (1995). Clozapine: Efficacy and safety. Schizophrenia Bulletin, 21, 579–591.

Buchanan, R. W., Breier, A., Kirkpatrick, B., Elkashef, A., Munson, R. C., Gellad, F., Carpenter, W. T., Jr. (1993). Structural abnormalities in deficit and non-deficit schizophrenia. American Journal of Psychiatry, 150, 59–65.

Buckley, P. F. (1997). New dimensions in the pharmacologic treatment of schizophrenia and related psychoses. Journal of Clinical Pharmacology, 37, 363–378.

Burke, K. C., Burke, J. D., Jr., Regier, D. A., & Rae, D. S. (1990). Age at the onset of selected mental disorders in five community populations. Archives of General Psychiatry, 47, 511–518.

Burke, M. J., Silkey, B., & Preskorn, S. H. (1994). Pharmacoeconomic considerations when evaluating treatment options for major depressive disorder. Journal of Clinical Psychiatry, 55(Suppl. A), 42–52.

Bymaster, F. P., Rasmussen, K., Calligaro, D. O., Nelson, D. L., DeLapp, N. W., Wong, D. T., & Moore, N. A. (1997). In vitro and in vivo biochemistry of olanzapine: A novel, atypical antipsychotic drug. Journal of Clinical Psychiatry, 58(Suppl. 10), 28–36.

Cadenhead, K. S., Geyer, M. A., Butler, R. W., Perry, W., Sprock, J., & Braff, D. L. (1997). Information processing deficits of schizophrenia patients: Relationship to clinical ratings, gender and medication status. Schizophrenia Research, 28, 51–62.

Calabrese, J. R., & Delucchi, G. A. (1990). Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. American Journal of Psychiatry, 147, 431–434.

Calev, A. (1994). Neuropsychology and ECT: Past and future research trends. Psychopharmacology Bulletin, 30, 461–469.

Callahan, D. (1999). Balancing efficiency and need in allocating resources to the care of persons with serious mental illness. Psychiatric Services, 50, 664–666.

Callahan, E. J., Bertakis, K. D., Azari, R., Robbins, J., Helms, L. J., & Miller, J. (1996). The influence of depression on physician-patient interaction in primary care. Family Medicine, 28, 346–351.

Cannon, T. D., Kaprio, J., Lonnqvist, J., Huttunen, M., & Koskenvuo, M. (1998). The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Archives of General Psychiatry, 55, 67–74.

Capleton, R. A. (1996). Cognitive function in schizophrenia: Association with negative and positive symptoms. Psychological Reports, 78, 123–128.

Cardno, A. G., & Farmer, A. E. (1995). The case for or against heterogeneity in the etiology of schizophrenia. The genetic evidence. Schizophrenia Research, 17, 153–159.

Carling, P. (1989). Access to housing: Cornerstone of the American dream. Journal of Rehabilitation, 55, 6–8.

Carpinello, S. E., & Knight, E. L. (1993). A survey of mental health self-help groups in New York state: Summary results. Albany, NY: New York State Office of Mental Health.

Casey, D. E. (1997). The relationship of pharmacology to side effects. Journal of Clinical Psychiatry, 58(Suppl. 10), 55–62.

Cassens, G., Inglis, A. K., Appelbaum, P. S., & Gutheil, T. G. (1990). Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16, 477–499.

Castrogiovanni, P., Iapichino, S., Pacchierotti, C., & Pieraccini, F. (1998). Season of birth in psychiatry. A review. Neuropsychobiology, 37, 175–181.

Cazzullo, C. L., Bertrando, P., Clerici, C., Bressi, C., Da Ponte, C., & Albertini, E. (1989). The efficacy of an information group intervention on relatives of schizophrenics. International Journal of Social Psychiatry, 35, 313–323.

Center for Mental Health Services. (1995). Double jeopardy: Persons with mental illnesses in the criminal justice system. Rockville, MD: Author.

Center for Mental Health Services. (1996). Consumer Affairs Bulletin, 1(1).

Center for Mental Health Services. (1997). Cultural competence standards in managed mental health care for four underserved/underrepresented racial/ethnic groups (Final report from Working Groups on Cultural Competence in Managed Mental Health Care). Rockville, MD: Author.

Center for Mental Health Services. (1998). Electroconvulsive therapy background paper (DHHS Publication No. SMA 98-3201). Vienna, VA: Research-Abele, Inc.

Chakos, M. H., Alvir, J. M., Woerner, M. G., Koreen, A., Geisler, S., Mayerhoff, D., Sobel, S., Kane, J. M., Borenstein, M., & Lieberman, J. A. (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Archives of General Psychiatry, 53, 313–319.

Chamberlin, J., & Rogers, J. A. (1990). Planning a community-based mental health system. Perspective of service recipients. American Psychologist, 45, 1241–1244.

Chambless, D. K., Baker, M. J., Baucom, D. H., Beutler, L. E., et al. (1998). Update on empirically validated therapies II. The Clinical Psychologist, 51, 3–16.

Charney, D. S., & Deutch, A. (1996). A functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders. Critical Reviews in Neurobiology, 10, 419–446.

Chouinard, G. (1988). The use of benzodiazepines in the treatment of manic-depressive illness. Journal of Clinical Psychiatry, 49(Suppl.), 15–20.

Christensen, A., & Heavey, C. L. (1999). Interventions for couples. Annual Review of Psychology, 50, 165B-190.

Ciompi, L. (1980). Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin, 6, 606–618.

Claghorn, J. L., & Feighner, J. P. (1993). A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. Journal of Clinical Psychopharmacology, 13, 23S–27S.

Clark, L. A., Watson, D., & Mineka, S. (1994). Temperament, personality, and the mood and anxiety disorders. Journal of Abnormal Psychology, 103, 103–116.

Clayton, P. J., & Darvish, H. S. (1979). Course of depressive symptoms following the stress of bereavement. In J. E. Barrett, R. M. Rose, & G. Klerman (Eds.), Stress and mental disorder (pp. 121–136). New York: Raven.

Clerc, G. E., Ruimy, P., & Verdeau-Palles, J. (1994). A double-blind comparison of venlaflaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. International Clinical Psychopharmacology, 9, 139–143.

Cohen, C. I. (1993). Poverty and the course of schizophrenia: Implications for research and policy. Hospital and Community Psychiatry, 44, 951–958.

Cohen, L. S., Friedman, J. M., Jefferson, J. W., Johnson, E. M., & Weiner, M. L. (1994). A reevaluation of risk of in utero exposure to lithium. Journal of the American Medical Association, 271, 146–150.

Back to Top

Home | Contents | Previous | Next